Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$163.98
+3.7%
$189.66
$153.77
$331.64
$12.07B1.69828,747 shs798,091 shs
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$72.09
+0.3%
$71.65
$58.93
$95.25
$42.38B1.154.79 million shs2.86 million shs
STERIS plc stock logo
STE
STERIS
$227.91
+1.0%
$223.22
$197.82
$248.24
$22.39B0.92527,589 shs401,009 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$112.54
+0.2%
$107.35
$97.69
$130.89
$22.40B1.041.56 million shs1.15 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
+3.73%-1.49%-6.35%-21.35%-47.45%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
+0.44%+1.37%+1.01%-0.69%-23.55%
STERIS plc stock logo
STE
STERIS
+1.07%+2.19%+2.49%+12.57%+5.48%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
+0.19%+1.76%+6.92%+7.74%-12.40%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Align Technology, Inc. stock logo
ALGN
Align Technology
4.5689 of 5 stars
4.42.00.03.83.31.71.3
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
4.6409 of 5 stars
3.23.00.04.03.12.52.5
STERIS plc stock logo
STE
STERIS
4.4657 of 5 stars
2.43.04.23.83.11.71.3
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.7515 of 5 stars
3.25.01.73.73.52.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.77
Moderate Buy$262.6460.16% Upside
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
2.40
Hold$79.9510.91% Upside
STERIS plc stock logo
STE
STERIS
2.80
Moderate Buy$258.7513.53% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.32
Hold$124.1510.32% Upside

Current Analyst Ratings Breakdown

Latest STE, EW, ALGN, and ZBH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/25/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$295.00 ➝ $250.00
3/18/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$270.00 ➝ $235.00
2/14/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$255.00
2/13/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$88.00 ➝ $90.00
2/13/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$68.00 ➝ $71.00
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Strong Sell
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$85.00 ➝ $85.00
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$70.00 ➝ $73.00
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$75.00 ➝ $73.00
2/12/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$70.00 ➝ $75.00
2/10/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$118.00 ➝ $113.00
(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$4.00B3.02$8.51 per share19.26$51.60 per share3.18
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$5.44B7.79$2.67 per share27.04$11.08 per share6.51
STERIS plc stock logo
STE
STERIS
$5.40B4.15$14.49 per share15.73$65.43 per share3.48
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.68B2.92$14.34 per share7.85$62.67 per share1.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$421.36M$5.6129.2318.322.2410.54%13.84%8.51%4/30/2025 (Estimated)
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$4.17B$6.9710.3426.214.8272.93%19.40%14.37%4/24/2025 (Estimated)
STERIS plc stock logo
STE
STERIS
$378.24M$4.7148.3922.95N/A8.66%13.91%8.64%5/6/2025 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.4525.2912.691.9511.77%12.99%7.58%5/1/2025 (Estimated)

Latest STE, EW, ALGN, and ZBH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.77N/AN/AN/A$1.89 billionN/A
4/30/2025N/A
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.00N/AN/AN/A$977.90 millionN/A
4/24/2025N/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.60N/AN/AN/A$1.40 billionN/A
2/11/2025Q4 2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.55$0.59+$0.04$0.65$1.36 billionN/A
2/6/2025Q4 24
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$2.30$2.31+$0.01$1.20$2.01 billionN/A
2/5/2025Q4 2024
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.43$1.96-$0.47$1.39$999.16 millionN/A
2/5/2025Q3 2025
STERIS plc stock logo
STE
STERIS
$2.33$2.32-$0.01$1.75$1.38 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
STERIS plc stock logo
STE
STERIS
$2.281.00%+9.51%48.41%20 Years
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.960.85%N/A21.57%N/A

Latest STE, EW, ALGN, and ZBH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.240.89%3/31/20253/31/20254/30/2025
1/28/2025
STERIS plc stock logo
STE
STERIS
quarterly$0.571.03%2/20/20252/20/20253/21/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.22
1.10
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
0.06
3.46
2.89
STERIS plc stock logo
STE
STERIS
0.32
2.13
1.40
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.43
1.91
0.99

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
79.46%
STERIS plc stock logo
STE
STERIS
94.69%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.62%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
1.29%
STERIS plc stock logo
STE
STERIS
1.14%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
21,61073.60 million74.19 millionOptionable
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
17,300587.87 million582.19 millionOptionable
STERIS plc stock logo
STE
STERIS
16,00098.25 million97.13 millionOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
18,000199.06 million197.18 millionOptionable

Recent News About These Companies

Zimmer Biomet wins CE mark for rib fixation system
1 S&P 500 Stock with Exciting Potential and 2 to Brush Off

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Align Technology stock logo

Align Technology NASDAQ:ALGN

$163.98 +5.90 (+3.73%)
Closing price 04/2/2025 04:00 PM Eastern
Extended Trading
$157.04 -6.94 (-4.23%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$72.09 +0.22 (+0.31%)
Closing price 04/2/2025 03:58 PM Eastern
Extended Trading
$70.25 -1.84 (-2.55%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

STERIS stock logo

STERIS NYSE:STE

$227.91 +2.19 (+0.97%)
Closing price 04/2/2025 03:58 PM Eastern
Extended Trading
$225.08 -2.84 (-1.24%)
As of 04:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$112.54 +0.17 (+0.15%)
Closing price 04/2/2025 03:58 PM Eastern
Extended Trading
$111.12 -1.43 (-1.27%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.